Mohammad Shahzaib Qadir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammad Shahzaib Qadir has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Eisha Saadat
Medical College, Aga Khan University Hospital, Sindh, Pakistan
2 shared publications - Arjun Chatterjee
Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic Foundation, Cleveland, OH
1 shared publication - Arsalan Syed
Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic Foundation, Cleveland, OH
1 shared publication - Hassan Siddiki
Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic Foundation, Cleveland, OH
1 shared publication - Jerry T. Dang
Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio
1 shared publication Om Parkash
Medical College, Aga Khan University Hospital, Sindh, Pakistan
1 shared publication
Latest Publications
- Open Access
- 9 November 2026
- Published by Springer Nature in Discover Medicine
- Vol. 3 (1) , 169
A comprehensive review of the pathophysiology and clinical management of caustic esophageal injury
Caustic ingestion is associated with substantial long-term morbidity and mortality. Complications range from acute perforation to progressive stricture formation, both of which impose a significant physical and financial burden on affected patients. The severity of gastrointestinal injury depends on several factors, including the type of substance ingested, its concentration, and the intent behind ingestion. Alkalis and acidic agents produce distinct patterns of tissue damage, causing liquefactive and coagulative necrosis, respectively. Pediatric exposures are typically accidental, whereas adult cases are more often intentional and associated with greater morbidity and mortality. In patients with suspected severe injury, early imaging with contrast-enhanced computed tomography has improved risk stratification and surgical decision-making. Endoscopy plays an essential role in initial evaluation in the first 24 h, while endoscopic dilation remains central to the management of chronic esophageal strictures. In highly selected or refractory cases, adjunctive therapies such as targeted corticosteroids or topical mitomycin C may be considered, though their routine use is not recommended. Long-term complications, including strictures, dysmotility, and malignancy, require ongoing surveillance. Preventive strategies, such as improved regulation of corrosive products and increased public awareness, are essential, particularly in high-risk populations. This narrative review summarizes the evolving diagnostic and therapeutic landscape of caustic esophageal injury and emphasizes a stratified approach to both acute management and chronic sequelae.
- 9 November 2026
- Published by Springer Nature in Discover Medicine
- Vol. 3 (1) , 169
Open AccessA comprehensive review of the pathophysiology and clinical management of caustic esophageal injury
Caustic ingestion is associated with substantial long-term morbidity and mortality. Complications range from acute perforation to progressive stricture formation, both of which impose a significant physical and financial burden on affected patients. The severity of gastrointestinal injury depends on several factors, including the type of substance ingested, its concentration, and the intent behind ingestion. Alkalis and acidic agents produce distinct patterns of tissue damage, causing liquefactive and coagulative necrosis, respectively. Pediatric exposures are typically accidental, whereas adult cases are more often intentional and associated with greater morbidity and mortality. In patients with suspected severe injury, early imaging with contrast-enhanced computed tomography has improved risk stratification and surgical decision-making. Endoscopy plays an essential role in initial evaluation in the first 24 h, while endoscopic dilation remains central to the management of chronic esophageal strictures. In highly selected or refractory cases, adjunctive therapies such as targeted corticosteroids or topical mitomycin C may be considered, though their routine use is not recommended. Long-term complications, including strictures, dysmotility, and malignancy, require ongoing surveillance. Preventive strategies, such as improved regulation of corrosive products and increased public awareness, are essential, particularly in high-risk populations. This narrative review summarizes the evolving diagnostic and therapeutic landscape of caustic esophageal injury and emphasizes a stratified approach to both acute management and chronic sequelae.
- 10 June 2026
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 28 (1) , 21
Management of Common Bile Duct Stones: Current Approaches and Evolving Endoscopic Strategies
Purpose of Review This review evaluates the evolving management strategies for common bile duct stones (CBDSs), focusing on standard endoscopic techniques, advanced intraductal interventions for refractory stones, and contemporary minimally invasive surgical options. Recent Findings While endoscopic retrograde cholangiopancreatography with sphincterotomy remains the cornerstone of therapy, recent evidence highlights the efficacy and safety of endoscopic papillary large balloon dilation and single-operator cholangioscopy-guided lithotripsy for difficult and refractory stones. Concurrently, laparoscopic common bile duct exploration has proven effective as a single-stage definitive treatment, demonstrating safety and stone clearance outcomes equivalent to the traditional two-stage endoscopic-surgical approach. Summary The management of CBDSs has shifted from a rigid, standardized protocol to a highly tailored clinical algorithm. No single gold-standard strategy is applicable to every scenario. Optimal outcomes are achieved through a flexible, multidisciplinary approach that customizes intervention based on stone characteristics, patient anatomy, and available institutional expertise.
- 10 June 2026
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 28 (1) , 21
Management of Common Bile Duct Stones: Current Approaches and Evolving Endoscopic Strategies
Purpose of Review This review evaluates the evolving management strategies for common bile duct stones (CBDSs), focusing on standard endoscopic techniques, advanced intraductal interventions for refractory stones, and contemporary minimally invasive surgical options. Recent Findings While endoscopic retrograde cholangiopancreatography with sphincterotomy remains the cornerstone of therapy, recent evidence highlights the efficacy and safety of endoscopic papillary large balloon dilation and single-operator cholangioscopy-guided lithotripsy for difficult and refractory stones. Concurrently, laparoscopic common bile duct exploration has proven effective as a single-stage definitive treatment, demonstrating safety and stone clearance outcomes equivalent to the traditional two-stage endoscopic-surgical approach. Summary The management of CBDSs has shifted from a rigid, standardized protocol to a highly tailored clinical algorithm. No single gold-standard strategy is applicable to every scenario. Optimal outcomes are achieved through a flexible, multidisciplinary approach that customizes intervention based on stone characteristics, patient anatomy, and available institutional expertise.
- Open Access
- 1 June 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (6) , e02185
Endoscopic Retrieval of a Migrated Plastic Pigtail Stent in a Patient With Gastric Bypass Surgery Using Novel Endoscopic Cutting Device
- 1 June 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (6) , e02185
Open AccessEndoscopic Retrieval of a Migrated Plastic Pigtail Stent in a Patient With Gastric Bypass Surgery Using Novel Endoscopic Cutting Device
- Open Access
- 5 March 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (1) , 123
Landscape of Measurable Residual Disease in Acute Myeloid Leukemia: From Molecular Detection to Clinical Practice
Measurable residual disease (MRD) has become a central determinant of prognosis and treatment planning in acute myeloid leukemia (AML). MRD assessment is now aided by a wide range of technologies, including next-generation sequencing, PCR-based assays, multiparameter flow cytometry, and emerging approaches such as liquid biopsy platforms and imaging-based detection. These modalities differ in sensitivity, applicability, and interpretive framework, yet each offers distinct advantages in specific disease contexts. Beyond technical issues, MRD is becoming increasingly integrated into clinical practice. In non-intensive treatment settings, where targeted and low-intensity regimens rely on dynamic disease monitoring to guide ongoing management, MRD is increasingly being used to inform therapeutic decisions. In the peri-transplant setting, MRD status influences conditioning strategies, donor selection, and the use of post-transplant interventions. Despite the growing evidence supporting the clinical relevance of MRD across these scenarios, challenges remain regarding standardization, optimal timing of assessment, and the interpretation of discordant results. This review summarizes the full landscape of MRD detection methods and examines the evolving role of MRD in contemporary AML management, emphasizing current applications and areas requiring further refinement.
- 5 March 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (1) , 123
Open AccessLandscape of Measurable Residual Disease in Acute Myeloid Leukemia: From Molecular Detection to Clinical Practice
Measurable residual disease (MRD) has become a central determinant of prognosis and treatment planning in acute myeloid leukemia (AML). MRD assessment is now aided by a wide range of technologies, including next-generation sequencing, PCR-based assays, multiparameter flow cytometry, and emerging approaches such as liquid biopsy platforms and imaging-based detection. These modalities differ in sensitivity, applicability, and interpretive framework, yet each offers distinct advantages in specific disease contexts. Beyond technical issues, MRD is becoming increasingly integrated into clinical practice. In non-intensive treatment settings, where targeted and low-intensity regimens rely on dynamic disease monitoring to guide ongoing management, MRD is increasingly being used to inform therapeutic decisions. In the peri-transplant setting, MRD status influences conditioning strategies, donor selection, and the use of post-transplant interventions. Despite the growing evidence supporting the clinical relevance of MRD across these scenarios, challenges remain regarding standardization, optimal timing of assessment, and the interpretation of discordant results. This review summarizes the full landscape of MRD detection methods and examines the evolving role of MRD in contemporary AML management, emphasizing current applications and areas requiring further refinement.